Is Gleevec as Good as Stem Cell Transplant in CML?

Posted by rob on January 31, 2011 under Uncategorized | Comments are off for this article

Researchers at Peking University Institute of Hematology have just published the results of their study which compared outcomes of imatinib mesylate (Gleevec) versus allogeneic stem cell transplant for patients with chronic myelogenous leukemia (CML) in accelerated phase (AP)….Read Full Post (Source: About.com Lymphoma)
More